25 XP   0   0   10

Capstone Therapeutics Corp
Buy, Hold or Sell?

Let's analyse Capstone Therapeutics Corp together

PenkeI guess you are interested in Capstone Therapeutics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Capstone Therapeutics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Capstone Therapeutics Corp

I send you an email if I find something interesting about Capstone Therapeutics Corp.

Quick analysis of Capstone Therapeutics Corp (30 sec.)










What can you expect buying and holding a share of Capstone Therapeutics Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$51.85
Expected worth in 1 year
$100.86
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$49.01
Return On Investment
942.4%

For what price can you sell your share?

Current Price per Share
$5.20
Expected price per share
$5.2 - $5.2
How sure are you?
50%

1. Valuation of Capstone Therapeutics Corp (5 min.)




Live pricePrice per Share (EOD)

$5.20

Intrinsic Value Per Share

$-122.07 - $-81.37

Total Value Per Share

$-70.22 - $-29.52

2. Growth of Capstone Therapeutics Corp (5 min.)




Is Capstone Therapeutics Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$8.1m$6.2m$1.9m23.6%

How much money is Capstone Therapeutics Corp making?

Current yearPrevious yearGrowGrow %
Making money$2.3m$3.9m-$1.6m-69.4%
Net Profit Margin3.8%5.9%--

How much money comes from the company's main activities?

3. Financial Health of Capstone Therapeutics Corp (5 min.)




4. Comparing to competitors in the Building Materials industry (5 min.)




  Industry Rankings (Building Materials)  

What can you expect buying and holding a share of Capstone Therapeutics Corp? (5 min.)

Welcome investor! Capstone Therapeutics Corp's management wants to use your money to grow the business. In return you get a share of Capstone Therapeutics Corp.

What can you expect buying and holding a share of Capstone Therapeutics Corp?

First you should know what it really means to hold a share of Capstone Therapeutics Corp. And how you can make/lose money.

Speculation

The Price per Share of Capstone Therapeutics Corp is $5.2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Capstone Therapeutics Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Capstone Therapeutics Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $51.85. Based on the TTM, the Book Value Change Per Share is $12.25 per quarter. Based on the YOY, the Book Value Change Per Share is $2.75 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Capstone Therapeutics Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps14.69282.5%14.69282.5%24.88478.4%18.07347.4%3.1059.6%
Usd Book Value Change Per Share12.25235.6%12.25235.6%2.7552.8%11.49220.9%-1.98-38.1%
Usd Dividend Per Share0.000.0%0.000.0%25.06482.0%5.0196.4%2.5148.2%
Usd Total Gains Per Share12.25235.6%12.25235.6%27.81534.8%16.50317.3%0.5210.1%
Usd Price Per Share37.00-37.00-17.25-20.65-10.40-
Price to Earnings Ratio2.52-2.52-0.69-0.52-0.25-
Price-to-Total Gains Ratio3.02-3.02-0.62-0.66-0.33-
Price to Book Ratio0.71-0.71-0.44-0.29-0.14-
Price-to-Total Gains Ratio3.02-3.02-0.62-0.66-0.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.2
Number of shares192
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.005.01
Usd Book Value Change Per Share12.2511.49
Usd Total Gains Per Share12.2516.50
Gains per Quarter (192 shares)2,352.343,167.56
Gains per Year (192 shares)9,409.3512,670.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10940993993850882112660
20188191880876991764125330
302822828217115492646238000
403763737626153983528350670
504704747035192484410463340
605645656444230975292476010
706586565853269476174588680
8075275752623079670566101350
9084684846713464679386114020
10094094940803849588207126690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%3.06.01.030.0%4.06.011.019.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%3.07.00.030.0%6.015.00.028.6%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%1.00.020.04.8%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%3.07.00.030.0%6.015.00.028.6%

Fundamentals of Capstone Therapeutics Corp

About Capstone Therapeutics Corp

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone veneer sidings, hardscapes and related moisture management products, lath products, and fireplaces offered under the Instone and Northeast Masonry names for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC

Fundamental data was last updated by Penke on 2024-03-29 14:27:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Capstone Therapeutics Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Capstone Therapeutics Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A Net Profit Margin of 3.8% means that $0.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Capstone Therapeutics Corp:

  • The MRQ is 3.8%. The company is making a profit. +1
  • The TTM is 3.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.8%TTM3.8%0.0%
TTM3.8%YOY5.9%-2.1%
TTM3.8%5Y-0.2%+4.0%
5Y-0.2%10Y-0.1%-0.1%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8%4.4%-0.6%
TTM3.8%5.5%-1.7%
YOY5.9%6.6%-0.7%
5Y-0.2%5.9%-6.1%
10Y-0.1%5.8%-5.9%
1.1.2. Return on Assets

Shows how efficient Capstone Therapeutics Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • 3.5% Return on Assets means that Capstone Therapeutics Corp generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Capstone Therapeutics Corp:

  • The MRQ is 3.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.5%TTM3.5%0.0%
TTM3.5%YOY6.4%-2.9%
TTM3.5%5Y-145.3%+148.9%
5Y-145.3%10Y-117.4%-27.9%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5%1.5%+2.0%
TTM3.5%1.6%+1.9%
YOY6.4%2.1%+4.3%
5Y-145.3%1.9%-147.2%
10Y-117.4%2.0%-119.4%
1.1.3. Return on Equity

Shows how efficient Capstone Therapeutics Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • 28.3% Return on Equity means Capstone Therapeutics Corp generated $0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Capstone Therapeutics Corp:

  • The MRQ is 28.3%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 28.3%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ28.3%TTM28.3%0.0%
TTM28.3%YOY62.8%-34.5%
TTM28.3%5Y54.2%-25.9%
5Y54.2%10Y-41.1%+95.3%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ28.3%2.7%+25.6%
TTM28.3%3.2%+25.1%
YOY62.8%4.0%+58.8%
5Y54.2%3.8%+50.4%
10Y-41.1%3.6%-44.7%

1.2. Operating Efficiency of Capstone Therapeutics Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Capstone Therapeutics Corp is operating .

  • Measures how much profit Capstone Therapeutics Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Capstone Therapeutics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-6.6%+6.6%
5Y-6.6%10Y-3.3%-3.3%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-9.6%
TTM-6.6%-6.6%
YOY-10.6%-10.6%
5Y-6.6%9.9%-16.5%
10Y-3.3%9.1%-12.4%
1.2.2. Operating Ratio

Measures how efficient Capstone Therapeutics Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Building Materials industry mean).
  • An Operation Ratio of 1.67 means that the operating costs are $1.67 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 1.667. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.667. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.667TTM1.6670.000
TTM1.667YOY1.686-0.019
TTM1.6675Y1.266+0.400
5Y1.26610Y0.633+0.633
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6671.587+0.080
TTM1.6671.542+0.125
YOY1.6861.393+0.293
5Y1.2661.382-0.116
10Y0.6331.210-0.577

1.3. Liquidity of Capstone Therapeutics Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Capstone Therapeutics Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Building Materials industry mean).
  • A Current Ratio of 1.76 means the company has $1.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 1.764. The company is able to pay all its short-term debts. +1
  • The TTM is 1.764. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.764TTM1.7640.000
TTM1.764YOY1.664+0.100
TTM1.7645Y2.194-0.430
5Y2.19410Y3.506-1.312
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7641.444+0.320
TTM1.7641.468+0.296
YOY1.6641.500+0.164
5Y2.1941.538+0.656
10Y3.5061.386+2.120
1.3.2. Quick Ratio

Measures if Capstone Therapeutics Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A Quick Ratio of 0.25 means the company can pay off $0.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.2550.000
TTM0.255YOY0.431-0.176
TTM0.2555Y0.211+0.044
5Y0.21110Y0.105+0.105
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2550.679-0.424
TTM0.2550.700-0.445
YOY0.4310.779-0.348
5Y0.2110.834-0.623
10Y0.1050.821-0.716

1.4. Solvency of Capstone Therapeutics Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Capstone Therapeutics Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Capstone Therapeutics Corp to Building Materials industry mean.
  • A Debt to Asset Ratio of 0.87 means that Capstone Therapeutics Corp assets are financed with 87.5% credit (debt) and the remaining percentage (100% - 87.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 0.875. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.875. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.875TTM0.8750.000
TTM0.875YOY0.897-0.023
TTM0.8755Y3.878-3.003
5Y3.87810Y2.286+1.591
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8750.438+0.437
TTM0.8750.442+0.433
YOY0.8970.449+0.448
5Y3.8780.462+3.416
10Y2.2860.466+1.820
1.4.2. Debt to Equity Ratio

Measures if Capstone Therapeutics Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A Debt to Equity ratio of 698.0% means that company has $6.98 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 6.980. The company is unable to pay all its debts with equity. -1
  • The TTM is 6.980. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ6.980TTM6.9800.000
TTM6.980YOY8.751-1.771
TTM6.9805Y4.836+2.144
5Y4.83610Y2.678+2.158
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9800.900+6.080
TTM6.9800.911+6.069
YOY8.7510.889+7.862
5Y4.8360.966+3.870
10Y2.6781.006+1.672

2. Market Valuation of Capstone Therapeutics Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Capstone Therapeutics Corp generates.

  • Above 15 is considered overpriced but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A PE ratio of 2.52 means the investor is paying $2.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Capstone Therapeutics Corp:

  • The EOD is 0.354. Based on the earnings, the company is cheap. +2
  • The MRQ is 2.519. Based on the earnings, the company is cheap. +2
  • The TTM is 2.519. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.354MRQ2.519-2.165
MRQ2.519TTM2.5190.000
TTM2.519YOY0.693+1.826
TTM2.5195Y0.515+2.004
5Y0.51510Y0.254+0.261
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD0.35412.296-11.942
MRQ2.51912.200-9.681
TTM2.51913.234-10.715
YOY0.69311.101-10.408
5Y0.51514.921-14.406
10Y0.25419.945-19.691
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Capstone Therapeutics Corp:

  • The EOD is -0.268. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.904. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.904. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.268MRQ-1.904+1.636
MRQ-1.904TTM-1.9040.000
TTM-1.904YOY1.066-2.970
TTM-1.9045Y1.237-3.140
5Y1.23710Y0.615+0.621
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD-0.2685.667-5.935
MRQ-1.9046.013-7.917
TTM-1.9045.991-7.895
YOY1.0662.128-1.062
5Y1.2375.330-4.093
10Y0.6155.068-4.453
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Capstone Therapeutics Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Building Materials industry mean).
  • A PB ratio of 0.71 means the investor is paying $0.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Capstone Therapeutics Corp:

  • The EOD is 0.100. Based on the equity, the company is cheap. +2
  • The MRQ is 0.714. Based on the equity, the company is cheap. +2
  • The TTM is 0.714. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.100MRQ0.714-0.613
MRQ0.714TTM0.7140.000
TTM0.714YOY0.436+0.278
TTM0.7145Y0.294+0.420
5Y0.29410Y0.143+0.151
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD0.1001.264-1.164
MRQ0.7141.190-0.476
TTM0.7141.117-0.403
YOY0.4361.287-0.851
5Y0.2941.420-1.126
10Y0.1431.532-1.389
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Capstone Therapeutics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--12.25212.2520%2.747+346%11.485+7%-1.983+116%
Book Value Per Share--51.85051.8500%39.598+31%19.079+172%15.773+229%
Current Ratio--1.7641.7640%1.664+6%2.194-20%3.506-50%
Debt To Asset Ratio--0.8750.8750%0.897-3%3.878-77%2.286-62%
Debt To Equity Ratio--6.9806.9800%8.751-20%4.836+44%2.678+161%
Dividend Per Share----0%25.062-100%5.012-100%2.506-100%
Eps--14.68814.6880%24.878-41%18.067-19%3.098+374%
Free Cash Flow Per Share---19.434-19.4340%16.186-220%-1.886-90%-7.440-62%
Free Cash Flow To Equity Per Share---0.171-0.1710%-1.218+611%-1.393+713%-3.582+1991%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max---81.369--------
Intrinsic Value_10Y_min---122.070--------
Intrinsic Value_1Y_max---1.551--------
Intrinsic Value_1Y_min---4.540--------
Intrinsic Value_3Y_max---9.691--------
Intrinsic Value_3Y_min---20.385--------
Intrinsic Value_5Y_max---23.899--------
Intrinsic Value_5Y_min---43.498--------
Market Cap819572.000-612%5831570.0005831570.0000%2718772.500+114%3255213.896+79%1639207.044+256%
Net Profit Margin--0.0380.0380%0.059-36%-0.002+106%-0.001+103%
Operating Margin----0%-0%-0.0660%-0.0330%
Operating Ratio--1.6671.6670%1.686-1%1.266+32%0.633+163%
Pb Ratio0.100-612%0.7140.7140%0.436+64%0.294+143%0.143+399%
Pe Ratio0.354-612%2.5192.5190%0.693+263%0.515+389%0.254+892%
Price Per Share5.200-612%37.00037.0000%17.250+114%20.654+79%10.400+256%
Price To Free Cash Flow Ratio-0.268+86%-1.904-1.9040%1.066-279%1.237-254%0.615-410%
Price To Total Gains Ratio0.424-612%3.0203.0200%0.620+387%0.661+357%0.325+829%
Quick Ratio--0.2550.2550%0.431-41%0.211+21%0.105+142%
Return On Assets--0.0350.0350%0.064-45%-1.453+4194%-1.174+3408%
Return On Equity--0.2830.2830%0.628-55%0.542-48%-0.411+245%
Total Gains Per Share--12.25212.2520%27.809-56%16.498-26%0.523+2241%
Usd Book Value--8172000.0008172000.0000%6241000.000+31%3007000.000+172%2486000.000+229%
Usd Book Value Change Per Share--12.25212.2520%2.747+346%11.485+7%-1.983+116%
Usd Book Value Per Share--51.85051.8500%39.598+31%19.079+172%15.773+229%
Usd Dividend Per Share----0%25.062-100%5.012-100%2.506-100%
Usd Eps--14.68814.6880%24.878-41%18.067-19%3.098+374%
Usd Free Cash Flow---3063000.000-3063000.0000%2551000.000-220%-297200.000-90%-1055300.000-66%
Usd Free Cash Flow Per Share---19.434-19.4340%16.186-220%-1.886-90%-7.440-62%
Usd Free Cash Flow To Equity Per Share---0.171-0.1710%-1.218+611%-1.393+713%-3.582+1991%
Usd Market Cap819572.000-612%5831570.0005831570.0000%2718772.500+114%3255213.896+79%1639207.044+256%
Usd Price Per Share5.200-612%37.00037.0000%17.250+114%20.654+79%10.400+256%
Usd Profit--2315000.0002315000.0000%3921000.000-41%2847600.000-19%488200.000+374%
Usd Revenue--61561000.00061561000.0000%66743000.000-8%37944800.000+62%18972400.000+224%
Usd Total Gains Per Share--12.25212.2520%27.809-56%16.498-26%0.523+2241%
 EOD+3 -5MRQTTM+0 -0YOY+16 -185Y+17 -1710Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of Capstone Therapeutics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.354
Price to Book Ratio (EOD)Between0-10.100
Net Profit Margin (MRQ)Greater than00.038
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.255
Current Ratio (MRQ)Greater than11.764
Debt to Asset Ratio (MRQ)Less than10.875
Debt to Equity Ratio (MRQ)Less than16.980
Return on Equity (MRQ)Greater than0.150.283
Return on Assets (MRQ)Greater than0.050.035
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Capstone Therapeutics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 505.200
Ma 50Greater thanMa 1005.200
Ma 100Greater thanMa 2005.254
OpenGreater thanClose5.200
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets65,212
Total Liabilities57,040
Total Stockholder Equity8,172
 As reported
Total Liabilities 57,040
Total Stockholder Equity+ 8,172
Total Assets = 65,212

Assets

Total Assets65,212
Total Current Assets20,972
Long-term Assets44,240
Total Current Assets
Cash And Cash Equivalents 23
Net Receivables 3,031
Inventory 17,398
Other Current Assets 520
Total Current Assets  (as reported)20,972
Total Current Assets  (calculated)20,972
+/-0
Long-term Assets
Property Plant Equipment 5,254
Long Term Investments 8,000
Long-term Assets Other 48
Long-term Assets  (as reported)44,240
Long-term Assets  (calculated)13,302
+/- 30,938

Liabilities & Shareholders' Equity

Total Current Liabilities11,888
Long-term Liabilities45,152
Total Stockholder Equity8,172
Total Current Liabilities
Short Long Term Debt 8,365
Total Current Liabilities  (as reported)11,888
Total Current Liabilities  (calculated)8,365
+/- 3,523
Long-term Liabilities
Long term Debt 16,915
Capital Lease Obligations Min Short Term Debt3,524
Long-term Liabilities  (as reported)45,152
Long-term Liabilities  (calculated)20,439
+/- 24,713
Total Stockholder Equity
Total Stockholder Equity (as reported)8,172
Total Stockholder Equity (calculated)0
+/- 8,172
Other
Common Stock Shares Outstanding 158
Net Debt 25,257
Net Invested Capital 33,452
Net Working Capital 9,084
Property Plant and Equipment Gross 6,523



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
65,035
49,697
53,420
130,106
115,184
88,343
72,589
61,862
49,514
37,135
25,288
14,696
11,591
7,317
3,385
1,767
1,182
1,569
1,477
284
54,874
60,853
65,212
65,21260,85354,8742841,4771,5691,1821,7673,3857,31711,59114,69625,28837,13549,51461,86272,58988,343115,184130,10653,42049,69765,035
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,719
1,258
829
1,373
1,438
284
16,029
15,271
20,972
20,97215,27116,0292841,4381,3738291,2582,71900000000000000
       Cash And Cash Equivalents 
6,753
19,503
11,286
84,357
40,377
35,111
18,047
20,943
23,088
12,874
24,387
13,778
10,205
6,258
2,164
1,011
748
1,275
1,341
58
0
50
23
23500581,3411,2757481,0112,1646,25810,20513,77824,38712,87423,08820,94318,04735,11140,37784,35711,28619,5036,753
       Short-term Investments 
2,492
11,008
18,660
32,499
51,642
46,437
35,977
18,236
22,675
22,268
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000022,26822,67518,23635,97746,43751,64232,49918,66011,0082,492
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,055
3,954
3,031
3,0313,9544,05500000000000000000000
       Other Current Assets 
3,650
3,318
2,265
882
1,019
857
1,950
906
1,094
1,660
643
758
383
233
357
247
81
98
1,190
267
459
321
520
5203214592671,19098812473572333837586431,6601,0949061,9508571,0198822,2653,3183,650
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
353
196
39
0
38,845
45,582
44,240
44,24045,58238,8450391963530000000000000000
       Property Plant Equipment 
11,094
1,902
1,498
560
478
525
409
318
436
333
258
160
23
3
0
0
0
0
0
0
6,092
5,933
5,254
5,2545,9336,0920000003231602583334363184095254785601,4981,90211,094
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
8,000
8,0008,000000000000000000000000
       Intangible Assets 
750
0
0
0
2,142
2,223
0
0
0
0
0
0
980
823
666
509
353
196
39
0
0
0
0
0000391963535096668239800000002,2232,142000750
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39
0
378
48
48
4848378039000000000000000000
> Total Liabilities 
0
0
0
0
0
4,165
3,441
2,401
1,992
2,407
1,816
119
294
100
282
1,261
1,304
2,448
2,721
4,226
49,066
54,612
57,040
57,04054,61249,0664,2262,7212,4481,3041,2612821002941191,8162,4071,9922,4013,4414,16500000
   > Total Current Liabilities 
9,797
6,914
4,835
5,851
4,117
3,982
3,441
2,401
1,992
2,407
1,816
119
294
100
282
261
304
199
246
1,155
11,037
9,178
11,888
11,8889,17811,0371,1552461993042612821002941191,8162,4071,9922,4013,4413,9824,1175,8514,8356,9149,797
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
2,249
0
0
0
0
0
000002,2491,0001,000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
2,249
0
0
6,441
5,710
8,365
8,3655,7106,441002,2491,0001,000000000000000000
       Accounts payable 
3,030
1,031
477
201
833
1,036
1,621
702
1,063
719
246
77
233
88
124
254
249
197
171
379
0
0
0
00037917119724925412488233772467191,0637021,6211,0368332014771,0313,030
       Other Current Liabilities 
6,767
5,883
4,358
2,726
3,170
2,946
1,820
1,699
929
1,688
1,570
42
61
12
158
7
0
0
75
776
536
43
0
043536776750071581261421,5701,6889291,6991,8202,9463,1702,7264,3585,8836,767
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
2,249
2,475
3,071
38,029
45,434
45,152
45,15245,43438,0293,0712,4752,2491,0000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,000
-1,000
-2,249
0
0
5,091
4,183
3,524
3,5244,1835,09100-2,249-1,000-1,000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
0
0
001300000000000000000000
> Total Stockholder Equity
55,150
42,496
48,233
123,975
110,930
84,178
69,148
59,461
47,522
34,728
23,472
14,577
11,104
7,217
3,103
506
-122
-879
-1,244
-3,301
5,808
6,241
8,172
8,1726,2415,808-3,301-1,244-879-1225063,1037,21711,10414,57723,47234,72847,52259,46169,14884,178110,930123,97548,23342,49655,150
   Common Stock
15
16
16
16
19
19
21
21
20
20
20
20
20
20
20
20
20
27
27
0
0
0
0
000027272020202020202020202121191916161615
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock0000000000000000000-137-137-1370
   Other Stockholders Equity 00000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue49,884
Cost of Revenue-38,609
Gross Profit11,27511,275
 
Operating Income (+$)
Gross Profit11,275
Operating Expense-49,860
Operating Income24-38,585
 
Operating Expense (+$)
Research Development-
Selling General Administrative11,251
Selling And Marketing Expenses-
Operating Expense49,86011,251
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,563
Other Finance Cost-0
Net Interest Income-1,563
 
Pretax Income (+$)
Operating Income24
Net Interest Income-1,563
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,53924
EBIT - interestExpense = -1,563
-2,279
-716
Interest Expense1,563
Earnings Before Interest and Taxes (EBIT)-24
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,539
Tax Provision-740
Net Income From Continuing Ops-2,279-2,279
Net Income-2,279
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,563
 

Technical Analysis of Capstone Therapeutics Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Capstone Therapeutics Corp. The general trend of Capstone Therapeutics Corp is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Capstone Therapeutics Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Capstone Therapeutics Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.2 < 5.2 < 5.2.

The bearish price targets are: 5.2 > 5.2 > 5.2.

Tweet this
Capstone Therapeutics Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Capstone Therapeutics Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Capstone Therapeutics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Capstone Therapeutics Corp. The current macd is -0.00121365.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Capstone Therapeutics Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Capstone Therapeutics Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Capstone Therapeutics Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Capstone Therapeutics Corp Daily Moving Average Convergence/Divergence (MACD) ChartCapstone Therapeutics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Capstone Therapeutics Corp. The current adx is 100.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Capstone Therapeutics Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Capstone Therapeutics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Capstone Therapeutics Corp. The current sar is 5.50420557.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Capstone Therapeutics Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Capstone Therapeutics Corp. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Capstone Therapeutics Corp Daily Relative Strength Index (RSI) ChartCapstone Therapeutics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Capstone Therapeutics Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Capstone Therapeutics Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Capstone Therapeutics Corp Daily Stochastic Oscillator ChartCapstone Therapeutics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Capstone Therapeutics Corp. The current cci is -66.66666667.

Capstone Therapeutics Corp Daily Commodity Channel Index (CCI) ChartCapstone Therapeutics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Capstone Therapeutics Corp. The current cmo is -100.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Capstone Therapeutics Corp Daily Chande Momentum Oscillator (CMO) ChartCapstone Therapeutics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Capstone Therapeutics Corp. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Capstone Therapeutics Corp Daily Williams %R ChartCapstone Therapeutics Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Capstone Therapeutics Corp.

Capstone Therapeutics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Capstone Therapeutics Corp. The current atr is 0.00021338.

Capstone Therapeutics Corp Daily Average True Range (ATR) ChartCapstone Therapeutics Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Capstone Therapeutics Corp. The current obv is -3,100.

Capstone Therapeutics Corp Daily On-Balance Volume (OBV) ChartCapstone Therapeutics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Capstone Therapeutics Corp. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Capstone Therapeutics Corp Daily Money Flow Index (MFI) ChartCapstone Therapeutics Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Capstone Therapeutics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Capstone Therapeutics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Capstone Therapeutics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 505.200
Ma 50Greater thanMa 1005.200
Ma 100Greater thanMa 2005.254
OpenGreater thanClose5.200
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Capstone Therapeutics Corp with someone you think should read this too:
  • Are you bullish or bearish on Capstone Therapeutics Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Capstone Therapeutics Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Capstone Therapeutics Corp

I send you an email if I find something interesting about Capstone Therapeutics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Capstone Therapeutics Corp.

Receive notifications about Capstone Therapeutics Corp in your mailbox!